Panama

Reimbursed Care Access

Panama maintains a restrictive statutory and enforcement approach to classic psychedelics (psilocybin, MDMA, DMT, mescaline, 2C‑series, etc.), which remain criminalized outside of authorized research. Ketamine is an established medical anesthetic and is procured and used within the public health system; however, the proprietary esketamine nasal spray (Spravato) does not appear in public Panamanian regulator procurement/communication records and there is no publicly available evidence of national registration or public reimbursement for Spravato as of February 20, 2026. Access to nearly all classic psychedelics is limited to participation in approved clinical trials or illicit markets.